Awards & Recognition

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early‑stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short‑ and long‑term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit, and which are not.

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early‑stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short‑ and long‑term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit, and which are not.

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early‑stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short‑ and long‑term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit, and which are not.

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early‑stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short‑ and long‑term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit, and which are not.

This Technion antisemitism panel discusses it persisting in U.S. academia for decades, calling for open dialogue and institutional change to combat this crisis.

Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla for extraordinary achievement in developing a vaccine for COVID-19 The President of the Technion – Israel Institute of Technology, Professor Uri Sivan announced that the Technion will award an honorary doctorate to Pfizer CEO

A Technion Innovation to capture COVID-19 viral particles with an active sanitization gel A Technion student team recently won a gold medal in the iGEM international synthetic biology competition for work developing an active gel to capture SARS-CoV-2 viral particles, preventing the infection of host